Research Projects
Characterization of amphiregulin as a new dual therapeutic target: protection against acute liver damage by ischemia and reperfusion and inhibition of neoplastic transformation of the liver
Researcher | Principal Investigator
Hepatology: Liquid Biopsy and Carcinogenesis Research Group
Research Division
Cancer Division
Research program
Solid Tumors
Research group
Hepatology: Liquid Biopsy and Carcinogenesis
Project information
Characterization of amphiregulin as a new dual therapeutic target: protection against acute liver damage by ischemia and reperfusion and inhibition of neoplastic transformation of the liver is a project of the Hepatology: Carcinogenesis (HEPACAN) research group of the Cima.
PI: Carmen Berasain
- Start date: January 1, 2008
- End date: December 31, 2010
- Funder: Instituto de Salud Carlos III
- Grant: 150.040 €)
- Nature of project: National
Need more information?
If you are interested in learning more about our research, please contact us.